Site Editor

Sandy Srinivas, MD


AUA 2023: Disparities Among Survivorship Programs for Genitourinary Cancer

By: Vanessa A. Carter, BS
Posted: Thursday, May 11, 2023

Currently, there is no information regarding survivorship programs that help patients with genitourinary cancers transition from active treatment to aid symptom management and improve surveillance compliance. To address this issue, Shree Agrawal-Patel, MD, of the Cleveland Clinic, and colleagues conducted a study to understand what survivorship resources currently exist among National Cancer Institute (NCI) cancer center websites. Their results were presented during the American Urological Association (AUA) Annual Meeting 2023 (Abstract MP06-18) and published in The Journal of Urology.

“Overall, a small portion of cancer centers provided information on genitourinary cancer survivorship care, and there is an interhospital variation on resources available to genitourinary cancer survivors,” the researchers concluded. “While treatment modalities for genitourinary cancers continue to improve, survivorship care for these cancers are lacking, indicating a need to further investigate evidence-based program features and definition.”

The NCI website was queried for a list of affiliated cancer centers (n = 66), and a Web-based search yielded the presence and available services of survivorship programs. Parameters included the specialty and credentials of survivorship providers, the presence of genitourinary cancer and general survivorship programs, methods of navigation to Web pages, and formal transition tools for cancer treatment to survivorship and surveillance.

A total of 19% of affiliated cancer centers had genitourinary cancer survivorship programs; 86% had a general cancer survivorship program. Among centers with genitourinary cancer programs, the information on survivorship programs was found on a cancer survivorship (58%), urology department (25%), or cancer care (17%) Web page. Provider composition was described in seven programs, with four listing physicians and three listing advanced practice providers. Of note, the average time patients were eligible for such programs was 8 months after treatment or 2 years after diagnosis. Although only 6 programs mentioned bladder cancer–specific resources, cancer care transitioning tools for survivorship were listed in 16 centers.

Disclosure: No disclosure information was provided.

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.